The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer’s Disease
Open accessAbstract
The human microbiome consists of ~3.8x1013 symbiotic microorganisms that form a highly complex and dynamic ecosystem: the gastrointestinal (GI) tract constitutes the largest repository of the human microbiome by far, and its impact on human neurological health and disease is becoming increasingly appreciated. Bacteroidetes, the largest phylum of gram-negative bacteria in the GI tract microbiome, while generally beneficial to the host when confined to the GI tract, have potential to secrete a remarkably complex array of pro-inflammatory neurotoxins that include surface lipopolysaccharides (LPSs) and toxic proteolytic species. The deleterious effects of these bacterial exudates appear to become more important as GI tract and blood-brain barriers alter or increase their permeability with aging and disease. For example, presence of the unique LPSs of the abundant Bacteroidetes species Bacteroides fragilis (BF-LPS) in the serum represents a major contributing factor to systemic inflammation. BF-LPS is further recognized by TLR2, TLR4 and/or CD14 microglial cell receptors as are the pro-inflammatory 42 amino acid amyloid-beta (Aβ42) peptides that characterize Alzheimer’s disease (AD) brain. Here we provide the first evidence that BF-LPS exposure to human primary brain cells is an exceptionally potent inducer of the pro-inflammatory transcription factor NF-kB (p50/p65) complex, a known trigger in the expression of pathogenic pathways involved in inflammatory neurodegeneration. This ‘Perspectives communication’ will in addition highlight work from recent studies that advance novel and emerging concepts on the potential contribution of microbiome-generated factors, such as BF-LPS, in driving pro-inflammatory degenerative neuropathology in the AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
A new view of the tree of life
Hug, L. A., Baker, B. J., Anantharaman, K., Brown, C. T., Probst, A. J., Castelle, C. J., Butterfield, C. N., Hernsdorf, A. W., Amano, Y., Ise, K., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.48 · Cited by 2,039
Neuroinflammation in Alzheimer's disease: current evidence and future directions
Calsolaro, V., & Edison, P. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.010 · Cited by 1,726
The blood-brain barrier in systemic inflammation
Varatharaj, A., & Galea, I. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.03.010 · Cited by 1,172 · cited 5×
“…CD14 microglial receptors to propagate and sustain inducible AD-relevant inflammatory responses within the CNS (Land, 2015; Zhao and Lukiw, 2015; Varatharaj and Galea, 2016); and (g) that LPS abundance, speciation and complexity in the CSF and/or blood serum may be useful diagnostically for…”
BackgroundInfluentialControl of brain development, function, and behavior by the microbiome
Sampson, T. R., & Mazmanian, S. K. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.011 · Cited by 1,093
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Lipopolysaccharide modification in Gram-negative bacteria during chronic infection
Maldonado, R. F., Sá-Correia, I., & Valvano, M. A. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw007 · Cited by 689
Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease
van de Haar, H. J., Burgmans, S., Jansen, J. F. A., van Osch, M. J. P., van Buchem, M. A., Muller, M., Hofman, P. A. M., Verhey, F. R. J., & Backes, W. H. (2016) · Radiology · doi:10.1148/radiol.2016152244 · Cited by 601
Zhang, L. S., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 500
Gut Microbiota and Inflammation
Hakansson, A., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 455
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Self-citationA comprehensive repertoire of prokaryotic species identified in human beings
Hugon, P., Dufour, J.-C., Colson, P., Fournier, P.-E., Sallah, K., & Raoult, D. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00293-5 · Cited by 403
The influence of non-steroidal anti-inflammatory drugs on the gut microbiome
Rogers, M. A. M., & Aronoff, D. M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.003 · Cited by 346
Alzheimer's disease and the microbiome
Bhattacharjee, S., & Lukiw, W. J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00153 · Cited by 248
Self-citationMicroglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
The ageing gastrointestinal tract
Soenen, S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2016) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000238 · Cited by 236
Zhang, J., Ke, K.-F., Liu, Z., Qiu, Y.-H., & Peng, Y.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075786 · Cited by 233
A Clinician's Primer on the Role of the Microbiome in Human Health and Disease
Khanna, S., & Tosh, P. K. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.10.011 · Cited by 227
Lukiw, W. J., & Bazan, N. G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5<583::aid-jnr8>3.0.co;2-5 · Cited by 189
Self-citationGut Microbiota and Brain Function: An Evolving Field in Neuroscience: Table 1.
Foster, J. A., Lyte, M., Meyer, E., & Cryan, J. F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv114 · Cited by 187
Can a Bacterial Endotoxin be a Key Factor in the Kinetics of Amyloid Fibril Formation?
Asti, A., & Gioglio, L. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-131394 · Cited by 180
Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).
Zhao, Y., & Lukiw, W. J. (2015) · PubMed · Cited by 174
Self-citationMicrobial-generated amyloids and Alzheimer's disease (AD)
Hill, J. M., & Lukiw, W. J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00009 · Cited by 173
Self-citationPathogenic microbes, the microbiome, and Alzheimer’s disease (AD)
(2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00127 · Cited by 169
Microbial Sources of Amyloid and Relevance to Amyloidogenesis and Alzheimer’s Disease (AD)
P, Z. Y. D. (2015) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000177 · Cited by 168
Land, W. G. (2015) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1676 · Cited by 164
Impact of the gut microbiota, prebiotics, and probiotics on human health and disease
Lai, H.-C., Young, J., Lin, C.-S., Chang, C.-J., Lu, C.-C., Martel, J., Ojcius, D., & Ko, Y.-F. (2014) · Biomedical Journal · doi:10.4103/2319-4170.138314 · Cited by 153 · cited 1×
“…the function and integrity of synapses, suggesting that the observed deficits in synaptic adhesion in Alzheimer’s disease (AD) play key roles in the progressive disruption of functional signaling throughout neuronal networks (Lin et al., 2014; Seong et al., 2015; Leshchyns’ka and Sytnyk, 2016).”
BackgroundJiang, Q., Jin, S., Jiang, Y., Liao, M., Feng, R., Zhang, L., Liu, G., & Hao, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9670-8 · Cited by 132
Infection, systemic inflammation, and Alzheimer's disease
Lim, S., Rodríguez‐Ortiz, C. J., & Kitazawa, M. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.04.004 · Cited by 128
Choi, V. M., Herrou, J., Hecht, A. L., Teoh, W. P., Turner, J. R., Crosson, S., & Wardenburg, J. B. (2016) · Nature Medicine · doi:10.1038/nm.4077 · Cited by 118
Cadherins and catenins in dendrite and synapse morphogenesis
Seong, E., Yuan, L., & Arikkath, J. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994919 · Cited by 105
Nishimori, J. H., Newman, T., Oppong, G. O., Rapsinski, G. J., Yen, J.-H. J., Biesecker, S. G., Wilson, R. P., Butler, B. P., Winter, M. G., Tsolis, R. M., et al. (2012) · Infection and Immunity · doi:10.1128/iai.00911-12 · Cited by 102
Synaptic Cell Adhesion Molecules in Alzheimer’s Disease
Leshchyns’ka, I., & Sytnyk, V. (2016) · Neural Plasticity · doi:10.1155/2016/6427537 · Cited by 98
Heinritz, S. N., Weiss, E., Eklund, M., Aumiller, T., Heyer, C. M. E., Messner, S., Rings, A., Louis, S., Bischoff, S., & Mosenthin, R. (2016) · Nutrients · doi:10.3390/nu8050317 · Cited by 92
Clark, I. A., & Vissel, B. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13181 · Cited by 84
Assessing the global phylum level diversity within the bacterial domain: A review
Youssef, N. H., Couger, M. B., McCully, A. L., Criado, A. E. G., & Elshahed, M. S. (2014) · Journal of Advanced Research · doi:10.1016/j.jare.2014.10.005 · Cited by 76
Synaptic Cell Adhesion Molecules
Bukalo, O., & Dityatev, A. E. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_5 · Cited by 66
Devier, D. J., Lovera, J. F., & Lukiw, W. J. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00005 · Cited by 66
Self-citationDistribution‐free Partially Sequential Tests for Treatments Versus Control Setting
Kim, D., & Wolfe, D. A. (1995) · Biometrical Journal · doi:10.1002/bimj.4710370302 · Cited by 60
Zhao, Y., Jaber, V. R., & Lukiw, W. J. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00140 · Cited by 59
Self-citationAnalysis of RNA from Alzheimer’s Disease Post-mortem Brain Tissues
Clement, C., Hill, J. M., Dua, P., Culicchia, F., & Lukiw, W. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9105-6 · Cited by 54
Self-citationActivation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure
Gustot, A., Raussens, V., Dehousse, M., Dumoulin, M., Bryant, C., Ruysschaert, J., & Lonez, C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1245-5 · Cited by 48
Richards, R. I., Robertson, S. A., O’Keefe, L. V., Fornarino, D. L., Scott, A., Lardelli, M. T., & Baune, B. T. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00193 · Cited by 42
Fathi, P., & Wu, S. (2016) · The Open Microbiology Journal · doi:10.2174/1874285801610010057 · Cited by 33
Understanding Microbiome Data: A Primer for Clinicians
Seksik, P., & Landman, C. (2015) · Digestive Diseases · doi:10.1159/000437034 · Cited by 28
Hofer, U. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3197 · Cited by 16
The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE
Halmer, R., Davies, L., Liu, Y., Fassbender, K. C., & Walter, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430351 · Cited by 13
P4‐236: ALZHEIMER'S DISEASE AND THE MICROBIOME
Hill, J. M., Lukiw, W. J., Clément, C., Bhattacharjee, S., & Zhao, Y. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.07.008 · Cited by 4
Self-citation
Cited by
Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx108 · Cited by 1,310
Gut Microbiota is Altered in Patients with Alzheimer’s Disease
Zhuang, Z.-Q., Shen, L.-L., Li, W.-W., Fu, X., Zeng, F., Gui, L., Lü, Y., Cai, M., Zhu, C., Tan, Y.-L., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180176 · Cited by 885
“It has been proved that some metabolites of gut microbiota can induce neuroinflammation [32].”
The Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826
Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804
Metadata
- Authors
- Lukiw, W. J.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-09-26
- Volume
- 7
- Pages
- 1544-1544
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2523727887
- Cited by
- 288
- References
- 51
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.